| abstract |
The invention provides compounds of formula (I) wherein R<1>, R<3>, R<4>, R<5>, R<14>, X and W are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase. |